Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate transporters are a family of membrane proteins responsible for the uptake of glutamate, the principal excitatory neurotransmitter in the central nervous system. These transporters play a critical role in maintaining low extracellular glutamate concentrations, thereby preventing excitotoxicity and ensuring proper synaptic signaling. Major subtypes include EAAT1, EAAT2, EAAT3, and EAAT4. Dysfunction can lead to elevated extracellular glutamate levels, resulting in neuronal damage or death due to excitotoxicity—a mechanism implicated in various neurological disorders such as epilepsy, amyotrophic lateral sclerosis (ALS), ischemia/stroke injury, and neurodegenerative diseases. These transporters operate as secondary active transporters, coupling the influx of glutamate with sodium and proton, while exporting potassium.
Modulation of glutamate transporter activity to regulate extracellular glutamate levels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate Transporter (None).